1. Toad venom bufadienolides and bufotoxins: An updated review
   Akmal M. Asrorov et al, 2023, Drug Development Research CrossRef
2. ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy
   Laura Soumoy et al, 2024, Cancer Cell International CrossRef
3. The γ-Benzylidene Digoxin Derivative BD-15 Increases the α3-Na, K-ATPase Activity in Rat Hippocampus and Prefrontal Cortex and no Change on Heart
   Gabriela Machado Parreira et al, 2021, The Journal of Membrane Biology CrossRef
4. 3-epi-bufotalin suppresses the proliferation in colorectal cancer cells through the inhibition of the JAK1/STAT3 signaling pathway
   SANHUA LI et al, 2022, BIOCELL CrossRef
5. A research update on the antitumor effects of active components of Chinese medicine ChanSu
   Jinhao Jia et al, 2022, Frontiers in Oncology CrossRef